表紙:脊椎用生物製剤の世界市場:製品別(脊椎同種移植、骨移植代替品、その他)、エンドユーザー別(病院、外来手術センター、その他)、地域別の市場規模調査と予測(2021年~2027年)
市場調査レポート
商品コード
1027506

脊椎用生物製剤の世界市場:製品別(脊椎同種移植、骨移植代替品、その他)、エンドユーザー別(病院、外来手術センター、その他)、地域別の市場規模調査と予測(2021年~2027年)

Global Spine Biologics Market is segmented by Product (Spinal Allografts, Bone Graft Substitutes, other), End User (Hospitals, Ambulatory Surgical Centers, Others), Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
脊椎用生物製剤の世界市場:製品別(脊椎同種移植、骨移植代替品、その他)、エンドユーザー別(病院、外来手術センター、その他)、地域別の市場規模調査と予測(2021年~2027年)
出版日: 2021年09月07日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脊椎用生物製剤の市場規模は、2021年~2027年の予測期間中に4%以上の健全な成長率で成長すると予想されています。

脊椎用生物製剤は、外傷、腫瘍、変性椎間板症、脊髄損傷などの脊椎の異常を治療するための脊椎固定手術において、炎症、治癒、リモデリングの段階で骨の成長生成を促進します。その結果、脊椎固定術の手術件数の増加に伴い、生物学的製剤の人気が高まっています。

市場を牽引しているのは、脊柱変形の有病率の上昇と高齢者人口の増加です。米国神経外科学会によると、米国では毎年1万7,000件の脊髄損傷が新たに発生しています。そのため、脊髄損傷の症例数は増加し、障害の治療が必要となります。さらに、多くの企業がドナーの体から採取した天然の骨を開発・提供しています。例えば、ジマー・バイオメット社は「RegenerOss Resorbable Xenograft」(天然骨移植片)を提供しています。このような世界的に有名な企業の製品が存在することは、脊椎骨移植の市場が存在することを示しています。

しかし、2021年から2027年の予測期間においては、償還政策が市場の成長を妨げる可能性があります。

当レポートでは脊椎用生物製剤の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、製品・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の定義と範囲

第3章 市場力学

  • 市場の影響分析(2019年~2027年)

第4章 業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 製品別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 脊椎同種移植
    • 骨移植代替品
    • その他

第6章 エンドユーザー別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 病院
    • 外来手術センター
    • その他

第7章 地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Stryker Corporation
    • Johnson And Johnson
    • Medtronic plc
    • Exactech, Inc
    • Orthofix Medical Inc.
    • Arthrex, Inc.
    • Spine Wave, Inc.
    • Zimmer Biomet
    • K2M Inc.
    • DePuy Synthes

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Spine Biologics Market, report scope
  • TABLE 2. Global Spine Biologics Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Spine Biologics Market estimates & forecasts by Product 2018-2027 (USD Billion)
  • TABLE 4. Global Spine Biologics Market estimates & forecasts by End User 2018-2027 (USD Billion)
  • TABLE 5. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Spine Biologics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Spine Biologics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. U.S. Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Canada Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Canada Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. UK Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. UK Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. Germany Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. Germany Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. France Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. France Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Spain Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Spain Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Italy Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Italy Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. ROE Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. ROE Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. China Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. China Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. India Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. India Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Japan Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Japan Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Australia Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Australia Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. South Korea Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. South Korea Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South KoreaSpine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. Brazil Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. Brazil Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Mexico Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Mexico Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. ROLA Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. ROLA Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROW Spine Biologics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROW Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Spine Biologics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. List of secondary sources used in the study of Global Spine Biologics Market.
  • TABLE 76. List of primary sources used in the study of Global Spine Biologics Market.
  • TABLE 77. Years considered for the study.
  • TABLE 78. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Spine Biologics Market, research methodology
  • FIG 2. Global Spine Biologics Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Spine Biologics Market, key trends 2020
  • FIG 5. Global Spine Biologics Market, growth prospects 2021-2027
  • FIG 6. Global Spine Biologics Market, porters 5 force model
  • FIG 7. Global Spine Biologics Market, pest analysis
  • FIG 8. Global Spine Biologics Market, value chain analysis
  • FIG 9. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Spine Biologics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Spine Biologics Market, regional snapshot 2018 & 2027
  • FIG 18. North America Spine Biologics Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Spine Biologics Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Spine Biologics Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Spine Biologics Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Spine Biologics Market, company market share analysis (2020)
目次

Global Spine Biologics Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4% over the forecast period 2021-2027. Spine biologics promote bone growth creation during the inflammatory, healing, and remodeling stages of spine fusion surgery for the treatment of spinal abnormalities such as trauma, tumors, degenerative disc disease, and spinal cord injuries. As a consequence, the popularity of biologics has been fueled by an increase in the number of spinal fusion surgeries. The market is driven by Growing Prevalence of Spine Deformities and Growing Geriatric Population. According to the American Association of Neurological Surgeons, 17,000 new cases of spinal cord injury are recorded in the United States each year. As a result, the number of cases of spinal cord injuries will increase leading to the need for treatment of disorders. Furthermore, a number of companies are developing and providing natural bone grafts harvested from the donor body. Zimmer Biomet, for example, offers RegenerOss Resorbable Xenograft (natural bone grafts). The presence of products from such well-known and worldwide firms indicates that there is a market for spinal bone grafts. However, reimbursement policies, may impede market growth over the forecast period of 2021-2027.

The global market for spine biologics is dominated by North America, followed by Europe. Stable economic growth, growing acceptance of minimally invasive procedures, and rising incidence of spine disorders such as spinal stenosis, disc-related problems, and spondylolisthesis are all factors contributing to the market's growth. Because of the vast patient pool and rising knowledge of biologics' advantages among surgeons and patients, the Asia Pacific market is expected to develop significantly. Improvements in the region's infrastructure and healthcare facilities, growing healthcare costs, and a high frequency of spine injuries are all factors drive the market growth.

Major market player included in this report are:

Stryker Corporation

Johnson And Johnson

Medtronic plc

Exactech, Inc

Orthofix Medical Inc.

Arthrex, Inc.

Spine Wave, Inc.

Zimmer Biomet

K2M Inc.

DePuy Synthes

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Spinal Allografts

Bone Graft Substitutes

other

By End user:

Hospitals

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Spine Biologics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Spine Biologics Market, by region, 2019-2027 (USD Billion)
    • 1.2.2. Spine Biologics Market, by Product, 2019-2027 (USD Billion)
    • 1.2.3. Spine Biologics Market, by End user, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Spine Biologics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Spine Biologics Market Dynamics

  • 3.1. Spine Biologics Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing Prevalence of Spine Deformities
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Restraint
      • 3.1.2.1. Reimbursement Policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in the biomaterial and minimally invasive procedure

Chapter 4. Global Spine Biologics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Spine Biologics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Spine Biologics Market by Product, Performance - Potential Analysis
  • 5.3. Global Spine Biologics Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
  • 5.4. Spine Biologics Market, Sub Segment Analysis
    • 5.4.1. Spinal Allografts
    • 5.4.2. Bone Graft Substitutes
    • 5.4.3. other

Chapter 6. Global Spine Biologics Market, by End user

  • 6.1. Market Snapshot
  • 6.2. Global Spine Biologics Market by End User, Performance - Potential Analysis
  • 6.3. Global Spine Biologics Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
  • 6.4. Spine Biologics Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centres
    • 6.4.3. Others

Chapter 7. Global Spine Biologics Market, Regional Analysis

  • 7.1. Spine Biologics Market, Regional Market Snapshot
  • 7.2. North America Spine Biologics Market
    • 7.2.1. U.S. Spine Biologics Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. End user breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Spine Biologics Market
  • 7.3. Europe Spine Biologics Market Snapshot
    • 7.3.1. U.K. Spine Biologics Market
    • 7.3.2. Germany Spine Biologics Market
    • 7.3.3. France Spine Biologics Market
    • 7.3.4. Spain Spine Biologics Market
    • 7.3.5. Italy Spine Biologics Market
    • 7.3.6. Rest of Europe Spine Biologics Market
  • 7.4. Asia-Pacific Spine Biologics Market Snapshot
    • 7.4.1. China Spine Biologics Market
    • 7.4.2. India Spine Biologics Market
    • 7.4.3. Japan Spine Biologics Market
    • 7.4.4. Australia Spine Biologics Market
    • 7.4.5. South Korea Spine Biologics Market
    • 7.4.6. Rest of Asia Pacific Spine Biologics Market
  • 7.5. Latin America Spine Biologics Market Snapshot
    • 7.5.1. Brazil Spine Biologics Market
    • 7.5.2. Mexico Spine Biologics Market
  • 7.6. Rest of The World Spine Biologics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Stryker Corporation
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Johnson And Johnson
    • 8.2.3. Medtronic plc
    • 8.2.4. Exactech, Inc
    • 8.2.5. Orthofix Medical Inc.
    • 8.2.6. Arthrex, Inc.
    • 8.2.7. Spine Wave, Inc.
    • 8.2.8. Zimmer Biomet
    • 8.2.9. K2M Inc.
    • 8.2.10. DePuy Synthes

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption